RIVANOVA
Pharmaceutical Manufacturing & Marketing
RIVANOVA Healthcare formulates, manufactures and markets a 480-SKU portfolio across seven dosage forms — under WHO-GMP certified systems, validated processes and analytical evidence that stands up to any audit, anywhere.
Audited, certified and approved by
About the company
RIVANOVA Healthcare Pvt Limited began in 2005 with a single oral-solids block and an uncomfortable question: why should affordable medicine be held to a lower standard than expensive medicine? Twenty years later we operate four dedicated production blocks, a 12,000 sq. ft. research centre and a distribution network reaching 25+ countries — and we still hold every batch to the same answer.
Oral Solids Block — Unit II
ISO Class 8 corridors · dedicated AHUs · 24×7 differential-pressure logging
Milestones
Incorporated with a single oral-solids block and 18 employees, supplying four districts in western India.
First WHO-GMP certification, opening institutional tenders and the first export consignments to South-East Asia.
Commissioned a dedicated formulation and analytical research centre, ending all reliance on third-party development.
Grade A/B aseptic injectable block validated, adding dry-powder and liquid vials to the portfolio.
Registrations live across 25+ countries with 480+ SKUs and a 1,200-strong distributor network.
By the numbers
Growth only counts if quality holds. These are the figures we review in every management meeting — capacity alongside conformance, reach alongside recall history.
Rotary compression · 6.2 lakh tablets/hour
In-line weight, hardness and thickness monitoring with automatic rejection
Manufacturing excellence
Four dedicated blocks separate oral solids, liquids, topicals and sterile production — no shared air, no shared handling, no cross-contamination risk. Each line is qualified through IQ, OQ and PQ before it makes a single saleable batch.
Independent AHUs, airlocks and material paths for every dosage form.
Weight, hardness, friability and fill-volume checked continuously, not by sampling alone.
Temperature, humidity and differential pressure recorded 24×7 with alarm escalation.
Every pack traceable to batch, line, shift and raw-material lot.
Why partners choose RIVANOVA
Doctors, hospitals, distributors and export partners each judge us differently. These are the commitments that hold across all of them.
An independent QA function with authority to reject, backed by ALCOA+ data integrity controls on every analytical instrument.
42 scientists developing in-house, so we can explain every excipient choice and defend every specification.
Dual-sourced APIs, 90-day safety stock on fast movers and a 98.4% on-time despatch record.
CTD and ACTD dossiers, CoPPs, DMFs, validation reports and ICH Zone IVb stability data on request.
Monopoly franchise rights district-wise, with promotional inputs and pricing protected for the agreed territory.
Every adverse-event report acknowledged within 24 hours and escalated to the national programme where required.
Quality & innovation
Quality assurance and research report independently of commercial targets. It slows some launches. It has never cost us a market.
Incoming materials, in-process stages and finished goods are all tested against pharmacopoeial monographs. Nothing ships on a certificate alone — we re-test what arrives, every time.
A 12,000 sq. ft. centre where formulation, analytical development and packaging science sit in the same corridor — so a stability signal reaches the formulator the same week, not the next quarter.
Our portfolio
From high-speed oral solids to Grade A aseptic vials — each with validated processes, documented stability and full regulatory support.
View all 480+ SKUsFilm-coated, enteric-coated, dispersible and sustained-release tablets produced on high-speed rotary presses inside dedicated, humidity-controlled oral-solid blocks.
Hard gelatin and vegetarian HPMC capsules filled under laminar airflow, with pellet-in-capsule and multi-unit particulate options for modified release.
Dry-powder and liquid vials filled in Grade A/B aseptic suites with online particle monitoring, terminal sterilisation and 100% visual inspection.
Industries served
Prescribing information, composition data and stability evidence delivered through a medical information desk — not a sales script.
Rate-contract supply, tender documentation, batch-wise CoAs and dedicated institutional service managers.
Territory-protected appointments, predictable fill rates, transparent credit terms and clear near-expiry policy.
CTD and ACTD dossiers, CoPPs, Free Sale Certificates and registration support through the full product lifecycle.
Third-party manufacturing under your brand with technology transfer, artwork development and NDA-governed confidentiality.
Capacity utilisation, therapeutic mix, export registrations and compliance history — reported without embellishment.
Global presence
Local agents, local registrations, local language artwork — supplied from a single qualified manufacturing base.
Certifications
Certification is a live commitment, re-audited every year by regulators, customers and our own quality assurance team.
WHO-GMP
ISO 9001:2015
ISO 14001:2015
GLP
Schedule M
FSSAI
Testimonials
Feedback collected from practising clinicians, hospital pharmacies and distribution partners across our territories.
“What I value is the consistency. Dissolution profiles hold from batch to batch, and when I have asked for stability data on a specific lot, it has arrived the same week — with the actual chromatograms, not a summary sheet.”
Dr. A. Kulkarni, MD
Consultant Physician · Pune
“Nine years as their distributor in central India. Fill rates hold above 96%, the near-expiry policy is written down and honoured, and I have never had to chase a credit note twice. That is rarer than it should be.”
R. Sharma
Super Stockist · Madhya Pradesh
“We audited the plant before our first order. Documentation was current, audit trails were reviewed before release rather than after, and no one hesitated when we asked to see a deviation file. That told us everything.”
M. Thiam
Regulatory Lead, Import Partner · West Africa
“For our paediatric ward the palatability of the suspensions genuinely matters — children finish the course. Combined with reliable institutional supply, it has made them our default for three therapy lines.”
Dr. S. Nair, DNB
Paediatrician, 220-bed Trust Hospital · Kerala
Newsroom
Approvals, capacity expansions, partnerships and recognitions — documented as they happen.
All newsMarketing authorisations granted for two anti-infective tablets and one paediatric suspension, taking live registrations past 180.
The new suite adds 1.7 lakh tablets per hour and dedicated handling for moisture-sensitive formulations.
Free diabetes and hypertension screening across 42 villages, with medicines dispensed at no cost to those diagnosed.
We hire for rigour and curiosity — in production, quality, R&D, regulatory affairs and commercial. Graduate trainees rotate through four functions in their first year.
Distribution, institutional supply, exports or contract manufacturing — tell us the territory and the therapy area, and we will respond within one working day.
We keep our facilities audit-ready year-round — current site master files, live validation records and documentation available on request. Come and look.